# Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients

> **NCT03003143** · NA · WITHDRAWN · sponsor: **Seoul National University Hospital**

## Conditions studied

- Autoimmune Encephalopathy

## Interventions

- **DRUG:** Vigabatrin 500 MG

## Key facts

- **NCT ID:** NCT03003143
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-11
- **Primary completion:** 2020-09-09
- **Final completion:** 2020-09-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2021-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003143, "Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03003143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*